Company Filing History:

8 out of 20

Societe Civile Bioprojet

patents

2 out of 1,744

Institut National De La Sante Et De La Recherche Medicale

4. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2006

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7094773 - [object Object] (2006-08-22),

2. 6878723 - LTA4 hydrolase inhibitors (2005-04-12),

3. 6835851 - Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids (2004-12-28),

4. 6436973 - LTA4 hydrolase inhibitors (2002-08-20),

5. 6013829 - Process for the asymmetric synthesis of S-acyl derivatives of (2000-01-11),

6. 5846956 - Amino acids derivatives, the process for their preparation and their (1998-12-08),

7. 5670531 - Amino acid derivatives, the process for their preparation and their (1997-09-23),

8. 5599951 - Amino acid derivatives, the process for their preparation and their (1997-02-04),

9. 5331008 - Thioester enantiomeric compounds and their therapeutic uses (1994-07-19),

10. 5296509 - Thioester enantiomeric compounds and their therapeutic uses (1994-03-22),

11. 5208255 - Thioester enantiomeric compounds and their therapeutic uses (1993-05-04),

12. 5136076 - Process for the preparation of amino acid-derived enatiomeric compounds (1992-08-04),

Title: Innovative Contributions of Jean-Christophe Plaquevent

Introduction: Jean-Christophe Plaquevent is a notable inventor from Notre Dame De Bondeville, France. With a remarkable portfolio of 12 patents, he has made significant advancements in the field of medicinal chemistry, particularly in anti-inflammatory compounds.

Latest Patents: Among his latest innovations, one prominent patent involves compounds that exhibit anti-inflammatory activity by inhibiting leukotriene A (LTA). This enzyme plays a crucial role in the biosynthesis of leukotriene LTB, which is a principal pro-inflammatory mediator. The invention not only details these compounds but also explores their therapeutic anti-inflammatory applications and methods for their preparation. Another notable patent addresses compounds that inhibit LTA4 hydrolase, which are of significant therapeutic interest, especially in treating inflammation.

Career Highlights: Throughout his career, Jean-Christophe has worked with esteemed organizations including Société Civile Bioprojet and Bioprojet. His contributions to medicinal chemistry and his innovative solutions have positioned him as a key figure in the development of effective anti-inflammatory treatments.

Collaborations: In his journey, Jean-Christophe has collaborated with distinguished professionals such as Denis Danvy and Pierre Duhamel. These partnerships have fostered an environment of innovation, enhancing his research and development efforts.

Conclusion: Jean-Christophe Plaquevent stands out as a prolific inventor whose work continues to influence the field of anti-inflammatory therapeutics. His inventive spirit and dedication to solving complex medical challenges have made a lasting impact, paving the way for future innovations in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com